First generic version of Gilead’s remdesivir will be sold by a Bangladesh drug maker

22 May 2020 - A drug maker in Bangladesh has become the first company to sell a generic version of ...

Read more →

Atomoxetine – further delay in change of funded brand and open access

20 May 2020 - PHARMAC is advising all interested parties that there is a further one-month delay in the listing ...

Read more →

CEO tapped by Trump to make generic drugs during pandemic has a dicey track record

19 May 2020 - As the chief executive of Phlow, the new company awarded $354 million by the federal government ...

Read more →

Teva Canada secures salbutamol inhalers from its global supply chain to mitigate shortage in Canadian market

19 May 2020 - Teva Canada to be first company to import emergency supply of salbutamol inhalers - providing access to ...

Read more →

The coronavirus exposed the US' reliance on India for generic drugs. But that supply chain is ultimately controlled by China

17 May 2020 - Sarah Thebarge, a 41-year-old physician assistant living in San Francisco, takes a pill every day to ...

Read more →

A drug company wagers the U.S. won’t dare charge it with crimes

15 May 2020 - Teva, the world’s largest maker of generic drugs, recently pulled out of settlement talks with the Justice ...

Read more →

The pandemic is a chance to revamp India’s pharmaceutical industry

9 May 2020 - Companies could switch from primarily making generics to producing higher-margin licensed drugs. ...

Read more →

Generic drug maker admits to fixing prices for cholesterol medication

7 May 2020 - For conspiring to inflate drug prices, Apotex will pay $24 million and cooperate with the Justice Department’s ...

Read more →

Commonwealth fails in its claim for compensation for delayed PBS listing of generic clopidogrel

29 April 2020 - The decision highlights the inherent difficulty Courts face in cases involving claims on the Usual Undertaking. ...

Read more →

Maker of drug touted as coronavirus cure accuses China of gouging

24 April 2020 - Hydroxychloroquine controversially pushed by Trump as COVID-19 remedy. ...

Read more →

Pharmacy reimbursement often lags for generics undergoing price hikes, jeopardising patient access

14 April 2020 - Of more than 4,300 instances in which pharmacies saw generic drug prices rise by 50% or ...

Read more →

Product specific guidances for chloroquine phosphate and hydroxychloroquine sulphate

13 April 2020 - The FDA plays a critical role in protecting the United States from threats including emerging infectious ...

Read more →

FDA approves first generic of a commonly used albuterol/salbutamol inhaler to treat and prevent bronchospasm

8 April 2020 - The U.S. FDA today approved the first generic of Proventil HFA (albuterol sulphate/salbutamol sulphate) metered dose inhaler, ...

Read more →

Trump administration in talks with India to avoid U.S. drug supply shortage

31 March 2020 - India, the top source of generic drugs and ingredients, has restricted exports but the U.S. wants exemptions ...

Read more →

Generic ‘identity’ gets lost when companies juggle both generic and brand drugs

17 March 2020 - We think we know generic drug companies. They challenge patents held by brand firms. They litigate ...

Read more →